Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-53.86%
Near historical average
Average (6y)
-51.86%
Historical baseline
Range
High:-1.91%
Low:-192.51%
CAGR
+73.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -53.86% | +37.3% |
| 2023 | -85.89% | +55.4% |
| 2022 | -192.51% | -698.9% |
| 2021 | -24.10% | -1159.1% |
| 2020 | -1.91% | +31.4% |
| 2019 | -2.79% | -43.1% |
| 2018 | -1.95% | - |